Advertisement
X

Breast Cancer Risk Factors & The Evolving Role Of Radiotherapy In Personalized Cancer Management - Dr. Abhilasha Maan

The future of breast cancer care lies in integrating AI, genomics, robotic surgery and adaptive radiotherapy. Precision medicine, advanced imaging and multidisciplinary care enable personalized treatment, improve disease control, reduce overtreatment and enhance quality of life.

Dr. Abhilasha Maan, Consultant - Radiation Oncology, Manipal Hospital Jaipur

Breast cancer remains one of the most common cancers in women globally and is on a continuous rise in both developed and developing countries. Improvements in screening, molecular diagnostics and therapeutics have greatly enhanced the chances of a patient surviving but earlier risk assessment and tailored treatment will continue to play a key role in improving outcomes. The way we treat breast cancer today has expanded to precision medicine, which means treatment is customized based on tumour biology, stage and patient characteristics.

What Increases the Risk of Breast Cancer?

Several biological, genetic and lifestyle factors contribute to breast cancer risk. Key risk factors include:

  • Age and Gender: Advancing age remains the strongest risk factor while women are more susceptible than men due to hormonal influences.

  • Genetic Changes: Inherited mutations in BRCA1, BRCA2, PALB2 and other susceptibility genes substantially increase lifetime cancer risk.

  • Hormonal Exposure: Early menstruation, late menopause and delayed childbirth elevate cumulative estragon exposure.

  • Lifestyle Factors: Obesity, physical inactivity, alcohol consumption, smoking and processed food items are associated with increased risk.

  • Family and Medical History: A strong family history, previous breast lesions, dense breast tissue or prior chest radiation increase risks.

How Is Personalized Breast Cancer Treatment Evolving?

Breast cancer management integrates genomic profiling, advanced imaging, and multidisciplinary planning to optimize treatment selection. Surgery remains the primary treatment for localized disease, ranging from breast-conserving procedures to mastectomy depending on tumour characteristics. Robotic-assisted breast surgery is gaining attention as a minimally invasive option for selected patients. Nipple-sparing mastectomy uses high-definition 3-D imaging and robotic articulation, which allows for greater precision, less tissue damage, better cosmetic results, smaller incisions and potentially faster recovery. Molecularly based therapies, immunotherapy, endocrine treatment, chemotherapy and radiotherapy provide treatments that provide personalized care.

Why Is Radiotherapy Becoming More Important?

Radiotherapy has key benefits like:

  • Improved Local Control: Precisely destroys residual microscopic cancer cells following surgery reducing local recurrence.

  • Breast Conservation: Enables breast conserving surgery by lowering recurrence rates without compromising survival in appropriately selected patients.

  • Advanced Precision Techniques: Technologies like IMRT, IGRT, VMAT and proton therapy improve dose conformity while protecting the heart, lungs and healthy breast tissue.

  • Personalized Treatment Planning: Radiation schedules are customized according to tumour subtype, genetic markers, surgical margins, lymph node involvement and patient anatomy.

  • Enhanced Quality of Life: Reduced treatment toxicity, shorter schedules and better cosmetic outcomes improve patient experience and support long-term health.

What Does the Future Hold for Breast Cancer Care?

The integration of AI, genomics, robotic surgery and adaptive radiotherapy into clinical practice is the future of breast cancer management. As a result of these predictive markers, a growing number of patients are treated at an intensity that avoids overtreatment and still achieves excellent disease control. Advanced imaging and real-time treatment planning further increase the precision of the therapies. While research is ongoing to further develop precision medicine, collaboration among multiple disciplines will continue as key to providing patient-centered, evidence-based care with a balance between survival and functional preservation and quality of life.

Breast cancer outcomes have improved considerably through earlier diagnosis, precision medicine, robotic surgical innovations and increasingly sophisticated radiotherapy techniques. Successful management still depends on timely detection. Women should remain aware of their personal risk profile, adopt healthy lifestyle practices and never ignore persistent breast changes. Regular breast screening, appropriate imaging based on age and risk, and quick consultation with a healthcare professional improve the chances of early diagnosis and successful treatment.

Published At:
US